Platelet counts and sickle cell disease in Saudi Arabia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how platelet counts relate to sickle cell disease in people living in the Eastern Region of Saudi Arabia. It aims to understand this relationship better in patients of all ages and genders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with sickle cell disease.
- There are no age or gender requirements.
- You cannot join if you do not have sickle cell disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different types of sickle cell disease (SS, S/beta0, S/C) are linked to blood clotting and disease severity. It may help doctors better understand the condition and how to treat it.
This trial looks at the cells that help make platelets (megakaryocytes) in people with sickle cell disease. By comparing these cells when you are feeling well and during a pain crisis or chest syndrome, researchers hope to learn more about the condition and find better treatments.
This study is a registry that collects information about people living with sickle cell disease. It may help researchers better understand sickle cell types in Germany, Austria, and Switzerland and support future research and care.
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
This study looks at how a person’s genes relate to certain measurements in red blood cells in people with sickle cell disease. The goal is to understand why blood cell function varies and how that might guide future care.
This study looks at differences in red blood cells and how likely they are to form clots in people with sickle cell disease. The goal is to better understand clot risk and what blood markers may predict it.
Hear when a new SCD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.